- Home
- ALHC vs IDYA Comparison
ALHC vs IDYA Comparison
Compare ALHC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALHC
- IDYA
- Stock Information
- Founded
- ALHC 2013
- IDYA 2015
- Country
- ALHC United States
- IDYA United States
- Employees
- ALHC N/A
- IDYA N/A
- Industry
- ALHC Medical Specialities
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- ALHC Health Care
- IDYA Health Care
- Exchange
- ALHC Nasdaq
- IDYA Nasdaq
- Market Cap
- ALHC 2.7B
- IDYA 2.3B
- IPO Year
- ALHC 2021
- IDYA 2019
- Fundamental
- Price
- ALHC $16.22
- IDYA $24.80
- Analyst Decision
- ALHC Buy
- IDYA Buy
- Analyst Count
- ALHC 11
- IDYA 13
- Target Price
- ALHC $18.14
- IDYA $48.09
- AVG Volume (30 Days)
- ALHC 3.7M
- IDYA 1.2M
- Earning Date
- ALHC 10-28-2025
- IDYA 11-03-2025
- Dividend Yield
- ALHC N/A
- IDYA N/A
- EPS Growth
- ALHC N/A
- IDYA N/A
- EPS
- ALHC N/A
- IDYA N/A
- Revenue
- ALHC $3,335,894,000.00
- IDYA $7,000,000.00
- Revenue This Year
- ALHC $47.18
- IDYA $62.30
- Revenue Next Year
- ALHC $28.45
- IDYA $285.58
- P/E Ratio
- ALHC N/A
- IDYA N/A
- Revenue Growth
- ALHC 49.46
- IDYA N/A
- 52 Week Low
- ALHC $8.82
- IDYA $13.45
- 52 Week High
- ALHC $21.06
- IDYA $37.80
- Technical
- Relative Strength Index (RSI)
- ALHC 60.73
- IDYA 51.00
- Support Level
- ALHC $15.02
- IDYA $23.23
- Resistance Level
- ALHC $17.30
- IDYA $27.69
- Average True Range (ATR)
- ALHC 0.65
- IDYA 1.35
- MACD
- ALHC -0.06
- IDYA -0.12
- Stochastic Oscillator
- ALHC 52.85
- IDYA 34.30
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.